Deschloroetizolam (Etizolam-2) is a thienodiazepine research compound structurally related to etizolam, distinguished by the absence of a chlorine substituent on the phenyl ring. This subtle structural modification makes deschloroetizolam of interest in pharmacological, analytical, and structure–activity relationship (SAR) research, particularly in studies examining benzodiazepine-receptor affinity and metabolic pathways.
In scientific literature and laboratory contexts, deschloroetizolam is referenced for comparative receptor-binding analysis, forensic toxicology calibration, and analytical method development. As a thienodiazepine analogue, it interacts with the GABA-A receptor complex, a central focus in CNS depressant research. Deschloroetizolam is not approved for medical use and may be regulated or controlled depending on jurisdiction, making compliance and documentation essential for legitimate research applications.
Due to growing interest in novel benzodiazepine analogues, deschloroetizolam continues to appear in academic discussions surrounding chemical modification, potency differentiation, and detection methodologies. All references to this compound are intended strictly for educational and research purposes.
Deschloroetizolam, Etizolam-2, thienodiazepine research chemical, etizolam analogue, benzodiazepine receptor study, forensic reference standard, SAR benzodiazepines
Authoritative References:
-
PubChem – Thienodiazepines (https://pubchem.ncbi.nlm.nih.gov)
-
Wikipedia – Thienodiazepine class (https://en.wikipedia.org)
-
NCBI / National Library of Medicine (https://www.ncbi.nlm.nih.gov)
